- Home
- Publications
- Publication Search
- Publication Details
Title
The Secret Life of Translation Initiation in Prostate Cancer
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-01-30
DOI
10.3389/fgene.2019.00014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells
- (2018) Xin Lian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer incidence in older adults, 2012 and 2035: A population-based study
- (2018) Sophie Pilleron et al. INTERNATIONAL JOURNAL OF CANCER
- Recent Advances in Prostate Cancer Treatment and Drug Discovery
- (2018) Ekaterina Nevedomskaya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer
- (2018) Laura Graham et al. INVESTIGATIONAL NEW DRUGS
- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
- (2018) Richard M. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Signaling Pathways Involved in the Regulation of mRNA Translation
- (2018) Philippe P. Roux et al. MOLECULAR AND CELLULAR BIOLOGY
- Development of a stress response therapy targeting aggressive prostate cancer
- (2018) Hao G. Nguyen et al. Science Translational Medicine
- Role of eIF2α Kinases in Translational Control and Adaptation to Cellular Stress
- (2018) Ronald C. Wek Cold Spring Harbor Perspectives in Biology
- Translational Control in Cancer
- (2018) Nathaniel Robichaud et al. Cold Spring Harbor Perspectives in Biology
- Phosphorylation and Signal Transduction Pathways in Translational Control
- (2018) Christopher G. Proud Cold Spring Harbor Perspectives in Biology
- Molecular Subtypes of Prostate Cancer
- (2018) Kaveri Arora et al. Current Oncology Reports
- Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis
- (2018) Praveen Kumar Jaiswal et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Global Burden of Urologic Cancers, 1990–2013
- (2017) Geolani W. Dy et al. EUROPEAN UROLOGY
- The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer
- (2017) L S D'Abronzo et al. ONCOGENE
- Eukaryotic translation initiation factors and cancer
- (2017) Muhammad Umar Ali et al. TUMOR BIOLOGY
- Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development
- (2017) Christos Vaklavas et al. Frontiers in Oncology
- The molecular and cellular origin of human prostate cancer
- (2016) John R. Packer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
- (2016) Hélène Malka-Mahieu et al. CLINICAL CANCER RESEARCH
- Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer
- (2016) Martine P. Roudier et al. PROSTATE
- Translational control by 5'-untranslated regions of eukaryotic mRNAs
- (2016) A. G. Hinnebusch et al. SCIENCE
- Signalling to eIF4E in cancer
- (2015) N. Siddiqui et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Molecular landscape of prostate cancer: Implications for current clinical trials
- (2015) Galina Khemlina et al. CANCER TREATMENT REVIEWS
- Differential Requirements for eIF4E Dose in Normal Development and Cancer
- (2015) Morgan L. Truitt et al. CELL
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer
- (2015) Yi Gao et al. MEDICAL ONCOLOGY
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors
- (2015) Andrew C. Hsieh et al. Science Signaling
- Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors
- (2015) Andrew C. Hsieh et al. Science Signaling
- Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
- (2015) Kimberly A. Herget et al. Cancer Medicine
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters
- (2015) Marjolaine Ngollo et al. BMC CANCER
- The Scanning Mechanism of Eukaryotic Translation Initiation
- (2014) Alan G. Hinnebusch Annual Review of Biochemistry
- PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
- (2014) AndrewC Hsieh et al. ASIAN JOURNAL OF ANDROLOGY
- Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer
- (2014) Liang Kee Goh et al. PLoS One
- Complex Impacts of PI3K/AKT Inhibitors to Androgen Receptor Gene Expression in Prostate Cancer Cells
- (2014) Liangliang Liu et al. PLoS One
- An expression signature at diagnosis to estimate prostate cancer patients’ overall survival
- (2014) Z Peng et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP
- (2013) Hu Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
- (2013) Rhonda L Bitting et al. ENDOCRINE-RELATED CANCER
- Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the α Subunit of the Translation Initiation Factor 2
- (2013) Ryan F. Overcash et al. PLoS One
- Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity
- (2013) K. Feoktistova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B
- (2013) Ke Ren et al. PROSTATE
- Genomic Rearrangements of PTEN in Prostate Cancer
- (2013) Sopheap Phin et al. Frontiers in Oncology
- Translation initiation in colorectal cancer
- (2012) Armen Parsyan et al. CANCER AND METASTASIS REVIEWS
- Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
- (2012) D. J. Mulholland et al. CANCER RESEARCH
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
- (2012) Himisha Beltran et al. EUROPEAN UROLOGY
- Targeting the PI3K pathway for cancer therapy
- (2012) Navid Sadeghi et al. Future Medicinal Chemistry
- The androgen receptor gene mutations database: 2012 update
- (2012) Bruce Gottlieb et al. HUMAN MUTATION
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Principles of Translational Control: An Overview
- (2012) J. W. B. Hershey et al. Cold Spring Harbor Perspectives in Biology
- Functional Characterization of an Isoform-Selective Inhibitor of PI3K-p110β as a Potential Anticancer Agent
- (2012) Jing Ni et al. Cancer Discovery
- A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
- (2011) Marco Auprich et al. BJU INTERNATIONAL
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
- (2011) T. W. Friedlander et al. CANCER RESEARCH
- Common Gene Rearrangements in Prostate Cancer
- (2011) Mark A. Rubin et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor
- (2011) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Characterization of KRAS Rearrangements in Metastatic Prostate Cancer
- (2011) Xiao-Song Wang et al. Cancer Discovery
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)
- (2010) Audrey Carriere et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
- (2010) Samson W Fine et al. MODERN PATHOLOGY
- Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
- (2010) Nallasivam Palanisamy et al. NATURE MEDICINE
- The mechanism of eukaryotic translation initiation and principles of its regulation
- (2010) Richard J. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
- (2010) L. Furic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
- (2009) David A. Guertin et al. CANCER CELL
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
- (2009) J. R. Graff et al. CANCER RESEARCH
- Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863and Multisite Phosphorylation
- (2009) Kathryn G. Foster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma
- (2009) Roula Albadine et al. MODERN PATHOLOGY
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
- (2009) F. I. Raynaud et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
- (2009) Regina Cencic et al. PLoS One
- Differential Requirement of mTOR in Postmitotic Tissues and Tumorigenesis
- (2009) C. Nardella et al. Science Signaling
- Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
- (2008) N. Rhodes et al. CANCER RESEARCH
- Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
- (2008) R. Mehra et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
- (2008) Carolyn Waugh Kinkade et al. JOURNAL OF CLINICAL INVESTIGATION
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis
- (2008) Shidong Jia et al. NATURE
- PTEN-deficient cancers depend on PIK3CB
- (2008) S. Wee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started